<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00854633</url>
  </required_header>
  <id_info>
    <org_study_id>LF-0901</org_study_id>
    <secondary_id>1R44HD057744-01A1</secondary_id>
    <nct_id>NCT00854633</nct_id>
  </id_info>
  <brief_title>Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants</brief_title>
  <official_title>Phase 1/2 Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Agennix</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Agennix</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the safety, toxicity and efficacy of talactoferrin in reducing the
      incidence of all nosocomial infections in prematurely-born infants.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2009</start_date>
  <completion_date type="Anticipated">December 2012</completion_date>
  <primary_completion_date type="Anticipated">March 2012</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction in incidence of Late-Onset Infection defined by positive cultures and elevated C-reactive protein (CRP)</measure>
    <time_frame>1-3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>&quot;NEC Scares&quot;, the &quot;Neonatal Sepsis Syndrome&quot;</measure>
    <time_frame>1-3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay: The number of days of hospitalization from the date of birth until the day of discharge from the NICU</measure>
    <time_frame>1-3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality during hospitalization</measure>
    <time_frame>1-3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Nosocomial Infections</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Talactoferrin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Talactoferrin</intervention_name>
    <description>Enteral, 150 mg/kg twice per day</description>
    <arm_group_label>1</arm_group_label>
    <other_name>talactoferrin alfa</other_name>
    <other_name>TLF</other_name>
    <other_name>recombinant human lactoferrin</other_name>
    <other_name>rhLF</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Oral, twice per day</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Birth weights ranging from 750 to 1500 grams

          -  Entry before 24 hours of age

          -  Informed-consent form signed by parent(s) or legal guardian

          -  Able to take liquid medication by mouth or feeding tube

        Exclusion Criteria

          -  A major birth defect or malformation syndrome

          -  Chromosomal or inherited disorder

          -  Proven presence of an immunodeficiency

          -  Antenatal exposure to illicit substances

          -  Birth asphyxia

          -  HIV or other congenital viral, bacterial, or fungal infection

          -  Lack of parental consent or refusal of attending neonatologist to allow participation

          -  Discretion of the investigator

          -  The legal representative of the infant or the patient's primary physician are not
             committed to providing full, aggressive life support
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>24 Hours</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rajesh Malik, MD</last_name>
    <phone>713-552-1091</phone>
    <email>rmalik@agennix.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Childrens Hospital of Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kosair Children's Hospital</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Louisville Hospital</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Missouri Health Care, Columbia Regional Hospital</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <zip>65201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 2, 2009</study_first_submitted>
  <study_first_submitted_qc>March 2, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2009</study_first_posted>
  <last_update_submitted>March 13, 2012</last_update_submitted>
  <last_update_submitted_qc>March 13, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 15, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pre-term infants</keyword>
  <keyword>Pre-term infants 750 to 1500 grams</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Cross Infection</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lactoferrin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

